Enhancement of Intestinal Model Compound Transport by DS-1, a Modified Quillaja Saponin
Authors:
- 1 November 1998
- journal article
- research article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 87 (11) , 1395-1399
Abstract
DS-1, a modified Quillaja saponin, has recently been shown to promote the absorption of insulin and aminoglycoside antibiotics via the ocular and nasal route. The purpose of this study is to investigate the effect of DS-1 on intestinal permeability, the mechanism of its action, and reversibility of the effect. The permeation-enhancing activity of DS-1 was evaluated in cultured monolayers of the Caco-2 intestinal epithelial cells by examining its effect on the transepithelial electric resistance (TEER) and on transport of mannitol and a model D-decapeptide. Mucosal addition of DS-1 promptly reduced the TEER of the Caco-2 monolayers, and a propensity of recovery of the TEER was observed upon its removal. DS-1 added at 0.01-0.1% (w/v) increased the transports of both mannitol and D-decapeptide in a dose-dependent manner; a relatively "flat" concentration-dependence was seen at 0.1-0.2%. Visualization studies conducted by confocal laser scanning microscopy (CLSM) seem to suggest that DS-1 enhances the Caco-2 permeability mainly via a transcellular route. Histological examination failed to reveal noticeable morphological alterations in the cell monolayers pretreated with DS-1. The integrity of the Caco-2 monolayers, as assessed by their permeability to mannitol, was found to be recoverable following the mucosal pretreatment of DS-1. These results suggest that DS-1 is an efficacious intestinal permeation-enhancing agent with low adverse effect on the epithelial viability and barrier function.Keywords
This publication has 19 references indexed in Scilit:
- Molecular Weight-Dependent Paracellular Transport of Fluorescent Model Compounds Induced by Palmitoylcarnitine Chloride across the Human Intestinal Epithelial Cell Line Caco-2Journal of Drug Targeting, 1998
- Structure/Function Studies on QS-21, A Unique Immunological Adjuvant from Quillaja saponaria1996
- DS-1, a Modified Quillaja Saponin, Enhances Ocular and Nasal Absorption of InsulinJournal of Pharmaceutical Sciences, 1995
- The Application of Cell Culture Systems in Drug Discovery and DevelopmentJournal of Drug Targeting, 1995
- Niflumic and flufenamic acids are potent inhibitors of chloride secretion in mammalian airwayLife Sciences, 1992
- Improvement of Systemic Absorption of Insulin Through Eyes with Absorption EnhancersJournal of Pharmaceutical Sciences, 1989
- Effect of Intranasal Growth Hormone-Releasing Hormone and Corticotropin-Releasing Hormone Administration on Growth Hormone and Cortisol Release: Improved Unavailability by Means of Sodium- Gly cocholateThe Journal of Clinical Endocrinology & Metabolism, 1989
- Nasal absorption of insulin: enhancement by hydrophobic bile salts.Proceedings of the National Academy of Sciences, 1985
- Adjuvant Activity of Saponin: Antigen Localization StudiesInternational Archives of Allergy and Immunology, 1985
- Route of Passive Ion Permeation in EpitheliaNature New Biology, 1972